We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
FLNA
151
Filana Therapeutics
FLNA
$39.4M
$39.4M $0.8157 6.77%
LITS
152
Lite Strategy Inc
LITS
$38.6M
$38.6M $1.27 9.93%
EDSA icon
153
Edesa Biotech
EDSA
$37.6M
$37.6M $3.90 4.84%
MGX icon
154
Metagenomi Therapeutics
MGX
$37.2M
$37.2M $0.9847 4.4%
BCTX
155
Briacell Therapeutics
BCTX
$34.8M
$34.8M $4 0.5%
ALGS icon
156
Aligos Therapeutics
ALGS
$33.2M
$33.2M $5.32 1.12%
NXTC icon
157
NextCure
NXTC
$30M
$30M $6.56 15.3%
IMMP
158
Immutep
IMMP
$29.9M
$29.9M $4.06 6.45%
RNAZ icon
159
TransCode Therapeutics
RNAZ
$29.8M
$29.8M $1.76 1.12%
GRDX
160
GridAI Technologies Corp
GRDX
$29.4M
$29.4M $4.12 1.2%
CNTX icon
161
Context Therapeutics
CNTX
$28.7M
$28.7M $0.3126 2.86%
EVAX
162
Evaxion A/S
EVAX
$28.5M
$28.5M $3.16 0%
MCRB icon
163
Seres Therapeutics
MCRB
$27.3M
$27.3M $2.72 6.21%
ATYR
164
aTyr Pharma
ATYR
$27.3M
$27.3M $0.2783 1.8%
QNCX icon
165
Quince Therapeutics
QNCX
$27.2M
$27.2M $26.72 0.34%
ABVC icon
166
ABVC BioPharma
ABVC
$26.7M
$26.7M $1 3.09%
BYSI icon
167
BeyondSpring
BYSI
$26.5M
$26.5M $0.6445 6.9%
QNTM
168
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$25.5M
$25.5M $3.15 1.94%
KYNB
169
Kyntra Bio
KYNB
$24.8M
$24.8M $6.13 2.85%
ATOS icon
170
Atossa Therapeutics
ATOS
$24.5M
$24.5M $2.46 0.41%
PLRZ
171
Polyrizon Ltd
PLRZ
$22.2M
$22.2M $9.15 5.38%
COCP icon
172
Cocrystal Pharma
COCP
$20.4M
$20.4M $1.06 4.5%
AKTX
173
Akari Therapeutics
AKTX
$19.7M
$19.7M $8.63 2.86%
ICU icon
174
SeaStar Medical
ICU
$19.6M
$19.6M $3.72 16.6%
JSPR icon
175
Jasper Therapeutics
JSPR
$19M
$19M $0.5697 1.71%
5 6
7
8 9

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 288 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $20.1B.

The largest by market cap are Immuneering (IMRX) at $250M, Nautilus Biotechnolgy (NAUT) at $249M and Vicore Pharma Holding AB ADS (VCRE) at $244M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.